tirzepatide vs semaglutide risks 2026: 22% vs 15% Weight Loss Guide Why You Might Tolerate One

Published in the New England Journal of Medicine in 2025, this Phase 3 study enrolled 610 Chinese adults with obesity or overweight accompanied by at least one weight-related comorbidity

What Causes Dumping Syndrome

Fernstrm, M., Fernberg, U

Furthermore, SGLT2i outperforms metformin in lowering body weight and FPG levels

Can I take semaglutide indefinitely or do I need to take breaks

By working collaboratively across the ecosystem, we help ensure that consumers have access to safe and effective solutions and medications. The End of the GLP-1 Shortage In October 2024, the FDA announced that the shortage of tirzepatide, the active ingredient in Mounjaro and Zepbound, was resolved, and shortages of other GLP-1s are also poised to be resolved in the near future